Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-08-31

FDA Approved: ZENATANE — Supplemental Application (BluePoint Laboratories)

View source ↗

Summary

FDA approved a supplemental application for ZENATANE (isotretinoin) filed by BluePoint Laboratories, approving changes to the existing labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ZENATANE (Isotretinoin)

Snippet

SUPPL AP for ZENATANE (ISOTRETINOIN)